Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

What happens when a bodybuilder loses his vision but refuses to give up? Meet Justin Holland, a competitive bodybuilder who ...

The longer weight loss GLP-1 drugs like Ozempic and Wegovy have been on the market, the more side effects people are reporting. In very rare cases they can be deadly. Here’s what to know.

The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.

SEVILLE, Spain — Treatment of optic neuritis with corticosteroids, findings from the Optic Neuritis Treatment Trial and the validity of previous treatment paradigms were debated at the ...

A patient with CLL initially presented with optic neuritis, and successful treatment with corticosteroids allowed a delay of systemic therapy.

Ophthalmic diseases specialist Oculis Holding AG announced positive phase II data showing its serum-glucose corticoid kinase-2 activator OCS-05 protected nerve cells and improved vision in patients ...

Gene therapy for rare eye disease safe but lacks efficacy in early trial A 28-patient phase 1 gene therapy clinical trial for the degenerative retinal disease Leber hereditary optic neuropathy ...